Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years.
Amyloid
; 24(3): 194-204, 2017 Sep.
Article
in En
| MEDLINE
| ID: mdl-28758793
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quality of Life
/
Benzoxazoles
/
Amyloid Neuropathies, Familial
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Amyloid
Journal subject:
BIOQUIMICA
Year:
2017
Document type:
Article
Affiliation country:
Argentina